# Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: the Italian National Health System perspective

> Research article (BMC Health Services Research, 2018) · cited 14× · AI/ML

**Wikidata**: [openalex:W2885945054](https://www.wikidata.org/wiki/openalex:W2885945054)  
**Source**: https://4ort.xyz/entity/budget-impact-analysis-of-the-use-of-extended-half-life-recombinant-factor-viii-efmoroctocog-alfa-for-the-treatment-of-c